- Report
- March 2025
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- May 2025
- 184 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- May 2025
- 196 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- March 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- July 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1344EUR$1,500USD£1,145GBP
- Report
- March 2025
- 210 Pages
Global
From €4474EUR$4,995USD£3,814GBP
- Report
- February 2025
- 130 Pages
Global
From €3910EUR$4,365USD£3,333GBP
€4344EUR$4,850USD£3,703GBP
- Report
- November 2024
- 90 Pages
North America
From €3090EUR$3,450USD£2,634GBP
- Report
- November 2024
- 84 Pages
Africa, Middle East
From €3090EUR$3,450USD£2,634GBP
- Report
- November 2024
- 90 Pages
Europe
From €3090EUR$3,450USD£2,634GBP
- Report
- November 2024
- 93 Pages
Asia Pacific
From €3090EUR$3,450USD£2,634GBP
- Report
- February 2021
- 420 Pages
United States
From €2150EUR$2,400USD£1,832GBP
- Report
- November 2018
- 147 Pages
Global
From €2463EUR$2,750USD£2,100GBP
- Report
- September 2023
- 120 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2023
- 150 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Drug Pipelines
- September 2022
- 280 Pages
Global
From €2150EUR$2,400USD£1,832GBP
- Report
- March 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- January 2024
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- May 2024
- 129 Pages
Global
From €5821EUR$6,499USD£4,962GBP

Tramadol is an opioid analgesic used to treat moderate to severe pain. It is a centrally acting synthetic opioid analgesic, similar to codeine, and is available in both immediate-release and extended-release formulations. Tramadol is used to treat a variety of conditions, including chronic pain, post-operative pain, and pain associated with cancer. It is also used to treat neuropathic pain, fibromyalgia, and other conditions. Tramadol is generally well-tolerated, but can cause side effects such as nausea, dizziness, and constipation.
The analgesic market is highly competitive, with a variety of products available. Tramadol is one of the most commonly prescribed analgesics, and is available in both generic and branded formulations. It is available in both oral and injectable forms, and is often used in combination with other analgesics.
Some companies in the Tramadol market include Mylan, Teva Pharmaceuticals, and Actavis. Show Less Read more